MAPT and Alzheimer disease: While considerable attention has been devoted to unraveling the causes and consequences of amyloid-beta (Aβ) plaque development and Tau-based neurofibrillary tangle (NFT) formation in the past three decades, recent studies have raised doubts regarding their proposed central roles in the reduced cognitive capacities in AD patients [9].